Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success.
about
Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection.How I treat mucormycosis.Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?Secondary Antifungal Prophylaxis in Hematopoietic Stem Cell Transplantation (HSCT)/Acute Leukemia Patients.Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.Posaconazole for primary antifungal prophylaxis in patients with acute myeloid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: a single-centre retrospective study in Korea and clinical considerations.A cost and resource utilization analysis of micafungin bridging for hemato-oncological high-risk patients undergoing allogeneic stem cell transplantation.Risk factors for invasive mold diseases in allogeneic hematopoietic cell transplant recipients.Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients.Evaluation of invasive aspergillosis risk of immunocompromised patients alternatively hospitalized in hematology intensive care unit and at home.Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies.Fungal Pneumonia in Patients with Hematologic Malignancy and Hematopoietic Stem Cell Transplantation.Methods of Controlling Invasive Fungal Infections Using CD8+ T Cells.
P2860
Q30585324-AC9632F3-A85D-4860-A537-D7A5FC850A6AQ35797637-51D1CB23-F6A2-4123-AFCF-231BD8DBA2A0Q37544662-6E1E0C7B-2C5B-43E8-9146-BB5E94E6E639Q37866827-EEE47591-B353-423A-A4B6-88F8AB85F0BDQ37935599-67283B9D-FE2D-4BE5-8362-B5F79B9AF415Q38644817-C0E3670C-3C38-470F-8632-F13A4675C911Q40691888-554F336A-30E5-4E57-9E75-660EA73C62ABQ41703438-2E3C3A92-F7B3-4874-90D6-8F668462AAFBQ42175368-2D62AEA8-0988-4D4F-886B-219EFFF02C39Q44636050-6EAF40A1-37CA-4D55-9C96-39415FB5D7BBQ46920426-62E9DE87-FCC4-4243-9915-844ED690E3E2Q47205373-0E93D2D6-B1CA-4C90-8528-C143FDA492EBQ47698782-0D10314E-7239-4E95-94C4-F19BA8527FF4Q47718243-52BB5FF8-E477-4D00-BD12-098B41C617D0
P2860
Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Antifungal prophylaxis in hema ...... hed tale of imperfect success.
@en
Antifungal prophylaxis in hema ...... hed tale of imperfect success.
@nl
type
label
Antifungal prophylaxis in hema ...... hed tale of imperfect success.
@en
Antifungal prophylaxis in hema ...... hed tale of imperfect success.
@nl
prefLabel
Antifungal prophylaxis in hema ...... hed tale of imperfect success.
@en
Antifungal prophylaxis in hema ...... hed tale of imperfect success.
@nl
P2860
P356
P1476
Antifungal prophylaxis in hema ...... hed tale of imperfect success.
@en
P2093
D P Kontoyiannis
P2860
P2888
P304
P356
10.1038/BMT.2010.256
P407
P577
2010-11-01T00:00:00Z